2018 update of the EULAR recommendations for the management of Behçet's syndromeGülen Hatemi, Hasan Yazıcı, Robin Christensen et al.|Annals of the Rheumatic Diseases|2018Cited by 771
EULAR recommendations for the management of Behçet diseaseGülen Hatemi, Hasan Yazıcı, Alan J. Silman et al.|Annals of the Rheumatic Diseases|2008Cited by 721
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalbán, Frauke Zipp, Ralf Gold et al.|Multiple Sclerosis Journal|2018Cited by 706
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Bernhard Hemmer, Yael Hacohen et al.|The Lancet Neurology|2021Cited by 518
Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical EventDarin T. Okuda, Christine Lebrun‐Frénay, Aksel Sıva et al.|PLoS ONE|2014Cited by 332